Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David O Arnar

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
European Journal of Clinical Investigation|March 19, 2011
Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgeryGudrun V Skuladottir, Ragnhildur Heidarsdottir, David O Arnar, et al.
Stroke|February 28, 2013
Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarctsHrafnhildur Stefansdottir, David O Arnar, Thor Aspelund, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 25, 2015
Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm AssociationM J Pekka Raatikainen, David O Arnar, Katja Zeppenfeld, et al.
Cardiology|August 17, 2013
Do high levels of n-3 polyunsaturated fatty acids in cell membranes increase the risk of postoperative atrial fibrillation?Lara Bjorgvinsdottir, David O Arnar, Olafur S Indridason, et al.
Scandinavian Cardiovascular Journal : SCJ|December 7, 2019
Immediate and long-term need for permanent cardiac pacing following aortic valve replacementSindri A Viktorsson, Andri W Orrason, Kristjan O Vidisson, et al.
Pilot and Feasibility Studies|December 1, 2022
Improving outpatient care for heart failure through digital innovation: a feasibility studyDavid O Arnar, Saemundur J Oddsson, Thrudur Gunnarsdottir, et al.
Journal of Thrombosis and Thrombolysis|February 20, 2017
Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trialAlma Rut Oskarsdóttir, Brynja R Gudmundsdottir, Olafur S Indridason, et al.
The Lancet. Haematology|December 22, 2015
Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trialPáll T Onundarson, Charles W Francis, Olafur S Indridason, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 13, 2017
Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholdersFrits W Prinzen, Nikolaos Dagres, Andreas Bollmann, et al.
European Heart Journal. Digital Health|July 24, 2025
Effect of a digital health intervention on outpatients with heart failure: a randomized, controlled trialDavid O Arnar, Bartosz Dobies, Elias F Gudmundsson, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Investigation|March 19, 2011
Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgeryGudrun V Skuladottir, Ragnhildur Heidarsdottir, David O Arnar, et al.
Stroke|February 28, 2013
Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarctsHrafnhildur Stefansdottir, David O Arnar, Thor Aspelund, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 25, 2015
Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm AssociationM J Pekka Raatikainen, David O Arnar, Katja Zeppenfeld, et al.
Cardiology|August 17, 2013
Do high levels of n-3 polyunsaturated fatty acids in cell membranes increase the risk of postoperative atrial fibrillation?Lara Bjorgvinsdottir, David O Arnar, Olafur S Indridason, et al.
Scandinavian Cardiovascular Journal : SCJ|December 7, 2019
Immediate and long-term need for permanent cardiac pacing following aortic valve replacementSindri A Viktorsson, Andri W Orrason, Kristjan O Vidisson, et al.
Pilot and Feasibility Studies|December 1, 2022
Improving outpatient care for heart failure through digital innovation: a feasibility studyDavid O Arnar, Saemundur J Oddsson, Thrudur Gunnarsdottir, et al.
Journal of Thrombosis and Thrombolysis|February 20, 2017
Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trialAlma Rut Oskarsdóttir, Brynja R Gudmundsdottir, Olafur S Indridason, et al.
The Lancet. Haematology|December 22, 2015
Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trialPáll T Onundarson, Charles W Francis, Olafur S Indridason, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 13, 2017
Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholdersFrits W Prinzen, Nikolaos Dagres, Andreas Bollmann, et al.
European Heart Journal. Digital Health|July 24, 2025
Effect of a digital health intervention on outpatients with heart failure: a randomized, controlled trialDavid O Arnar, Bartosz Dobies, Elias F Gudmundsson, et al.
Pageof 9